Both in Pharmaceuticals
Celularity vs CervoMed
Over the past year CELU returned −36.3% and CRVO returned −64.4%; their daily moves had a correlation of 0.04.
CELU −36.3% CRVO −64.4%Growth of $1, one year, split-adjusted
| Metric | CELU | CRVO |
|---|---|---|
| Price | $1.37 | $2.88 |
| Market cap | $43.4M | $43.5M |
| Today | −2.14% | +7.87% |
| 1 month | −13.3% | +10.8% |
| 6 months | +8.7% | −20.4% |
| Year to date | +23.4% | −63.5% |
| 1 year | −39.1% | −65.2% |
| Revenue growth (YoY) | −77.4% | −100.0% |
| Gross margin | −79.7% | — |
| Net margin | −595.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.6× | 131.4× |
| Net cash | -$41.6M | $24.9M |
| Dividend yield | — | — |
| Volatility (60d) | 204.2% | 61.5% |
| Short % of float | 11.5% | 14.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).